UK Health Regulator warns about Mirvaso and cardiovascular effects

  The regulator of healthcare products in the UK has issued a Drug Safety Update related to the topical treatment for the red face of rosacea – Mirvaso. This update was issued in June 2017 and seems to have gone largely unnoticed by rosacea sufferers online. Here is why it has been issued, and what […]

Leo Pharma is the new owner of Finacea

News today that Bayer HealthCare is selling its prescription dermatology business to the unlisted Danish company Leo Pharma. Leo Pharma now becomes an interesting company for rosacea sufferers given the prevalence and efficacy of both Finacea and Finacea Foam. The future of these products and any related funded research now rests with Leo Pharma. LEO […]